OCUPHIRE PHARMA INC. - COMMON STOCK
1.5800
21-六月-24 14:59:52
15 分钟延时
股票
-0.0200
-1.25%
今日范围
1.5450 - 1.6450
ISIN
N/A
来源
NASDAQ
-
06 6月 2024 06:57:22 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 06:14:52 条件 Nasdaq GlobeNewswire
-
08 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 2月 2024 15:10:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
05 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 1月 2024 15:10:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 11月 2023 15:38:14 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 11月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 11月 2023 15:52:46 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >